ARTG 208442Clinical chemistry substrate IVDs - Clinical chemistry substrate IVDs
ARTG ID: 208442 · Plexus RA Pty Ltd · Bionime Corporation · Class IIb · Started April 19, 2013
Good Name: Plexus RA Pty Ltd- Clinical chemistry substrate IVDs
- Risk Class
- Class IIb
- Product Type
- IVD
- ARTG Category
- IVD
- ARTG ID
- 208442
- Start Date
- April 19, 2013
- Effective Date
- March 15, 2019
- Country
- Taiwan
- Address
- No 100 Sec2 Daqing Street South Dist, Taichung City, Taichung City, 40242
The blood glucose monitoring system is used by individuals with diabetes. It is for the checking on glucose levels in capillary whole blood, as an aid in management of diabetes at home and clinical sites.
Access comprehensive regulatory information for Clinical chemistry substrate IVDs - Clinical chemistry substrate IVDs in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is registered under ARTG number 208442 and sponsored by Plexus RA Pty Ltd, manufactured by Bionime Corporation in Taiwan. The device registration started on April 19, 2013.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.